Literature DB >> 2342600

Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection.

K Fuxe1, A M Janson, A Jansson, K Andersson, P Eneroth, L F Agnati.   

Abstract

In order to further study the previously demonstrated protective action of chronic nicotine treatment on lesioned meso-striatal dopamine (DA) pathways, the following study was carried out on DA utilization in these lesioned neurons. Male Sprague-Dawley rats were partially hemitransected at the meso-diencephalic junction and treated with nicotine (0.125 mg.kg-1.h-1) by means of Alzet minipumps implanted subcutaneously for 2 weeks. The overall serum nicotine level obtained was 64.6 +/- 2.7 ng.ml-1. The results demonstrated that partial di-mesencephalic hemitransections produced a marked reduction of DA fluorescence (quantitative histofluorimetry) on the lesioned side in the nucleus caudatus putamen, anterior nucleus accumbens and posterior lateral tuberculum olfactorium. No significant effects were observed on the intact side. Furthermore, studies on changes in DA utilization as evaluated 2 h after tyrosine hydroxylase inhibition showed an augmentation in the alpha-methyl-(+/-)-p-tyrosine methyl ester (alpha-MT)-induced depletion of the DA stores on the hemitransected side in comparison with the operated side of the sham-operated animals. On the hemitransected side chronic nicotine treatment increased DA stores in the DA nerve terminals of the nucleus caudatus putamen and the posterior lateral tuberculum olfactorium. No significant effects were observed on the intact side. Following chronic nicotine treatment a marked and preferential attenuation of the alpha-MT-induced depletion of DA stores was seen in the various DA nerve terminal systems of the forebrain on the hemitransected side. In the substantia nigra reduced DA levels (HPLC) were demonstrated on the hemitransected side, while no effects on the non-operated side were observed. Also an increase of the alpha-MT-induced depletion of the DA stores was seen on the hemitransected side in comparison with the operated side of the sham-operated animals. In contrast, on the non-operated side an attenuation of the alpha-MT-induced depletion of the DA stores was found. Following chronic nicotine treatment the lesion induced reduction of the nigral DA stores on the hemitransected side was counteracted, as was the lesion induced increase in the alpha-MT-induced depletion of DA stores, which was replaced by a reduction of the alpha-MT-induced depletion of the nigral DA stores. However, on the non-operated side an increased DA depletion was observed after alpha-MT treatment in rats treated chronically with nicotine. Chronic nicotine treatment under the present conditions did not significantly alter serum levels of corticosterone and reduced prolactin serum levels in sham-operated rats.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2342600     DOI: 10.1007/bf00169727

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection.

Authors:  A M Janson; K Fuxe; L F Agnati; I Kitayama; A Härfstrand; K Andersson; M Goldstein
Journal:  Brain Res       Date:  1988-07-12       Impact factor: 3.252

2.  Nicotine dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigations.

Authors:  N L Benowitz; H Porchet; P Jacob
Journal:  Prog Brain Res       Date:  1989       Impact factor: 2.453

3.  Epidemiologic studies of Parkinson's disease. 3. A community-based survey.

Authors:  I I Kessler
Journal:  Am J Epidemiol       Date:  1972-10       Impact factor: 4.897

Review 4.  Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain.

Authors:  I N Mefford
Journal:  J Neurosci Methods       Date:  1981-02       Impact factor: 2.390

5.  Chronic nicotine treatment eliminates asymmetry in striatal glucose utilization following unilateral transection of the mesostriatal dopamine pathway in rats.

Authors:  C Owman; K Fuxe; A M Janson; J Kåhrström
Journal:  Neurosci Lett       Date:  1989-07-31       Impact factor: 3.046

6.  Smoking and Parkinson's disease.

Authors:  R B Godwin-Austen; P N Lee; M G Marmot; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-07       Impact factor: 10.154

7.  A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing.

Authors:  T Hökfelt; L Skirboll; J F Rehfeld; M Goldstein; K Markey; O Dann
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

8.  Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons.

Authors:  P B Clarke; A Pert
Journal:  Brain Res       Date:  1985-12-02       Impact factor: 3.252

9.  Cigarette smoking and Parkinson disease: 1. Comparison of cases with matched neighbors.

Authors:  R J Baumann; H D Jameson; H E McKean; D G Haack; L M Weisberg
Journal:  Neurology       Date:  1980-08       Impact factor: 9.910

10.  Effects of acrylonitrile on rat liver cytochrome P-450, benzo(a)pyrene metabolism and serum hormone levels.

Authors:  O G Nilsen; R Toftgard; P Eneroth
Journal:  Toxicol Lett       Date:  1980-10       Impact factor: 4.372

View more
  10 in total

1.  Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice.

Authors:  R E Ryan; S A Ross; J Drago; R E Loiacono
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 2.  Nicotine: abused substance and therapeutic agent.

Authors:  J Le Houezec
Journal:  J Psychiatry Neurosci       Date:  1998-03       Impact factor: 6.186

Review 3.  Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms.

Authors:  G Mudo; N Belluardo; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2006-08-17       Impact factor: 3.575

4.  Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse.

Authors:  A M Janson; K Fuxe; M Goldstein
Journal:  Clin Investig       Date:  1992 Mar-Apr

5.  Hypertrophy of dopamine neurons in the primate following ventromedial mesencephalic tegmentum lesion.

Authors:  A M Janson; K Fuxe; M Goldstein; A Y Deutch
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

6.  Chronic continuous infusion of nicotine increases the disappearance of choline acetyltransferase immunoreactivity in the cholinergic cell bodies of the medial septal nucleus following a partial unilateral transection of the fimbria fornix.

Authors:  K Fuxe; L Rosén; A Lippoldt; B Andbjer; U Hasselrot; U B Finnman; L F Agnati
Journal:  Clin Investig       Date:  1994-03

7.  Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity.

Authors:  D R Helton; D L Modlin; J P Tizzano; K Rasmussen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease.

Authors:  J R James; A Nordberg
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

9.  Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei.

Authors:  R Klink; A de Kerchove d'Exaerde ; M Zoli; J P Changeux
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

10.  Rotating and Neurochemical Activity of Rats Lesioned with Quinolinic Acid and Transplanted with Bone Marrow Mononuclear Cells.

Authors:  Teresa Serrano Sánchez; María Elena González Fraguela; Lisette Blanco Lezcano; Esteban Alberti Amador; Beatriz Caballero Fernández; María de Los Ángeles Robinson Agramonte; Lourdes Lorigados Pedre; Jorge A Bergado Rosado
Journal:  Behav Sci (Basel)       Date:  2018-09-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.